Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #82989 on NorthWest Biotherapeutics Inc (NWBO)
nbinvest
11/14/16 6:06 PM
#82990 RE: exwannabe #82989
flipper44
11/14/16 6:09 PM
#82991 RE: exwannabe #82989
The Company and its representatives are in discussions with the Nasdaq Staff regarding available avenues for remediation, and the Company intends to submit its plan of remediation to Nasdaq on or before the November 18, 2016 deadline established by Nasdaq. If Nasdaq does not accept the plan of remediation, Nasdaq may issue a notice of delisting. The Company would then have the right to request a hearing before an independent Nasdaq Listing Qualifications Panel (the “Panel”). A request for a hearing would stay any suspension or delisting action pending the hearing and the expiration of any additional extension period granted by the Panel. The Panel would have the discretion to grant the Company an extension period of up to 180 calendar days from the date of the delisting letter within which the Company would be required to demonstrate compliance with all applicable listing requirements. -- November 10, 2016 10Q
chinatown1980
11/14/16 7:46 PM
#83004 RE: exwannabe #82989